News
Cantor Fitzgerald Reiterates Overweight on VolitionRX, Maintains $2.5 Price Target
27 Mar 24
News, Price Target, Reiteration, Analyst Ratings
EF Hutton Maintains Buy on VolitionRX, Maintains $4.5 Price Target
27 Mar 24
News, Price Target, Analyst Ratings
VolitionRX Q4 EPS $(0.11), Inline, Sales $243.97K Miss $450.00K Estimate
25 Mar 24
Earnings, News
VolitionRx Cash And Cash Equivalents As Of December 31, 2023, Totaled ~$20.7M
25 Mar 24
Earnings, News
Earnings Scheduled For March 25, 2024
25 Mar 24
Earnings
Earnings Outlook For VolitionRX
22 Mar 24
Earnings
Press releases
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
25 Mar 24
Earnings, Press Releases
VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
21 Mar 24
Press Releases
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
20 Mar 24
Press Releases
Volition appoints Dr Andrew Retter as Chief Medical Officer
19 Mar 24
Press Releases
Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar
2 Feb 24
Press Releases